Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. | PLoS One;10(7): e0134190, 2015. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.

Sirgel, Frederick A; Warren, Robin M; Böttger, Erik C; Klopper, Marisa; Victor, Thomas C; van Helden, Paul D.

PLoS One ; 10(7): e0134190, 2015.

Article in En | MEDLINE | ID: mdl-26197053

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Country of publication: